Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC

NCT06762379 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT06762379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06762379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC
Lead sponsor
European Institute of Oncology
Phase
Observational
Overall status
Recruiting
Start date
December 20, 2024
Completion date
December 31, 2030
Enrollment
125 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostate cancer (mpc)